Bariatric surgery plus GLP-1 drug for weight loss and diabetes
Part of Hormones & metabolism clinical trials.
This study tests if adding a GLP-1 medication to weight-loss surgery helps people with obesity and related conditions like diabetes. It may improve weight loss and blood sugar control more than surgery alone.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your body mass index (BMI) must be 27.5 or higher.
- You must have metabolic syndrome or type 2 diabetes.
- You must be between 16 and 70 years old.
- You can't have taken a GLP-1 drug in the last 6 months.
- You can't have had any weight-loss surgery before.
- You must be healthy enough for surgery (no severe liver, kidney, cancer, or mental health issues).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a GLP-1 receptor agonist (a medication that helps control blood sugar and appetite) after weight loss surgery improves outcomes for people with severe obesity and related health problems like type 2 diabetes.
This trial tests whether adding a GLP-1 medication (a type of diabetes and weight-loss drug) after weight-loss surgery helps patients with obesity and related health conditions like diabetes. Researchers want to see if combining surgery with this medicine works better than surgery alone.
This study tests whether bariatric (weight-loss) surgery can improve blood sugar control in people with obesity and either prediabetes or type 2 diabetes. You may be enrolled in one of these glucose groups, and the researchers will monitor changes before and after surgery.
This trial studies bariatric (weight-loss) surgery and how well it helps people reach and keep a healthier weight. You may qualify if you have severe obesity and have not been able to maintain weight loss with other attempts, and if you can safely follow the study plan.
This trial tests a type of weight-loss surgery (called metabolic surgery) to see if it helps people with type 2 diabetes achieve better blood sugar control. It's for people who have struggled to manage their diabetes with standard treatments and have a BMI between 30 and 35.
This study looks at how taking a GLP-1 medicine (like Ozempic or Wegovy) affects your fat tissue before bariatric surgery. It compares people who have taken a GLP-1 for at least 3 months to those who never have.
Hear when a new Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.